Kathryn Tan

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 164 citations

Bone Disease, Osteopathy, Loft Extension Study +10

Hypertriglyceridaemia and vascular risk

Kathryn Tan, D. J. Betteridge, Michael Marmot et al. · The Lancet · 1993 · 49 citations

Obesity, Metabolic Syndrome, Hypertension +11

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

Eliot A. Brinton, Uma Kher, Sukrut Shah et al. · Journal of clinical lipidology · 2014 · 27 citations

Specific Patient Subgroups, Pharmacology, Cetp Inhibition +6

Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study

Eden David, Neda Shokrian, Ester Del Duca et al. · Archives of Dermatological Research · 2024 · 20 citations · Full text

Successful treatment of juvenile pityriasis rubra pilaris with ustekinumab in a 7-year-old girl

L Bonomo, Aishwarya Raja, Kathryn Tan et al. · JAAD Case Reports · 2018 · 19 citations · Full text

Successful Treatment, Pathogenesis, 7-Year-old Girl +12